Drugs / Marine liquid and fluids
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05054075 | Oct 2021 → Oct 2022 | COVID-19, severe acute respiratory syndrome | University of Porto | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Marine liquid and fluids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05054075 ↗ |